1 / 24

HIV/HCV co-infection in Taiwan

HIV/HCV co-infection in Taiwan. Nai-Ying Ko RN. PhD., Hsin-Chun Lee MD, Shainn-Wei Wang PhD., Wen-Chien Ko MD, National Cheng Kung University & Hospital Taiwan. Topics. Molecular epidemiology of HIV/HCV coinfection in Taiwan

gene
Download Presentation

HIV/HCV co-infection in Taiwan

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HIV/HCV co-infection in Taiwan Nai-Ying Ko RN. PhD., Hsin-Chun Lee MD, Shainn-Wei Wang PhD., Wen-Chien Ko MD, National Cheng Kung University & Hospital Taiwan

  2. Topics • Molecular epidemiology of HIV/HCV coinfection in Taiwan • Treatment and care for patient with HIV/HCV coinfection in Taiwan • Challenges of management of HIV/HCV coinfection in Taiwan

  3. Annual Numbers of Newly Reported HIV Cases by Mode of Transmission, 1984-2007 Cumulative number of reported HIV cases: 15,866 (June 30, 2008) Harm reduction Free HAART 2462 1813 629 713 Year

  4. Free AZT Free HAART HIV/AIDS Reported Case Number and Fatality Rates in Taiwan, 1984 – 2006 *: AIDS-related deaths / AIDS case number

  5. 台北縣 桃園縣 新竹縣 Age-adjusted prevalence of anti-HCV 宜蘭縣 苗栗縣 0 - 1% 1 - 3% 3 - 5% 台中縣 5 -10% 彰化縣 南投縣 花蓮縣 雲林縣 嘉義縣 台南縣 高雄縣 台東縣 屏東縣 Anti-HCV prevalence in Taiwan • Population: 157,720 adults • Period: 1996-2005 • Anti-HCV seropositivity: 4.4% • HCV genotype distribution • 1b: 58~81.1 % • 2a: 7.4~12 % • 2b: 3.4~4.9 % • Chen CH at al., J Formos Med • Assoc. 2007;106(2):148-55 • Yu ML et al, J. Med. Virol. 2001;65:58-65

  6. Extremely high prevalence of HCV infection among HIV-infected IDUs in Taiwan Liu JY, et al. , Clinical Infectious Diseases 2008; 46:1761–8

  7. The proposed route of HIV/HCV transmission from China and Southeast Asia to Taiwan Liu JY, et al. , Clinical Infectious Diseases 2008; 46:1761–8

  8. Co-Infections among HIV-Infected Adults [J Formos Med Assoc 2008;107(5):404–411]

  9. Serological characteristics and types of HBV and HCV of 146 HIV-1-infected adults categorized by HIV risky groups in NCKUH

  10. HCV infection is significantly associated with HIV infection among gay bathhouse attendees in Taiwan, 2004-2007 * * Odds ratio: 7.1; 95% CI: 2.3-22.1 NY Ko, at al. (2008) unpublished data

  11. Topics • Molecular epidemiology of HIV/HCV coinfection in Taiwan • Treatment and care for paitents with HIV/HCV conifection in Taiwan • Challenges of management of HIV/HCV coinfection in Taiwan

  12. HBV/HCV Treatment in Taiwan • 1980s Department of Health • Hepatitis Prevention Act • 2003 Bureau of National Health Insurance • program for strengthening treatment for chronic hepatitis B and C • 2007 National Health Research Institute • National Forum on screening, treatment and long-term follow-up of patients with hepatitis B virus- or hepatitis C virus-related liver diseases

  13. Treatment of Chronic Hepatitis C (National Health Insurance, Taiwan) • Criteria • Anti-HCV (+) , • ALT ≧ 2X, 3 M apart, within 6 M • Fibrosis ≧ F2 • ( F1, since August, 2004 ) • PEG-IFN or IFN + RBV for 24 weeks

  14. Screening for HIV/HCV coinfection in Taiwan • Test of anti-HCV for all patients with HIV • Test of HCV RNA for patients with HIV • Anti-HCV(+) and progression to chronic hepatitis • Anti-HCV(-), rapid progression with abnormal liver function tests, and patients with low CD4 cell counts (< 200 cells/mm3) • Anti-HCV(-), suspect acute HCV infection (NHRI National Hepatitis BC Forum, 2008)

  15. Preparation for HIV/HCV coinfection treatment in Taiwan • Before treatment • Liver function tests (AST, ALT), HCV RNA, HCV genotype, liver biopsy • HIV RNA, CD4 cell counts • Optimized HAART treatment • When considering treatment • CD4 >350 cells/mm3, treat HCV first • If CD4 =201-350 cells/mm3, treat HIV first then HCV • CD4 < 200 cells/mm3, treat HIV (NHRI National Hepatitis BC Forum, 2008)

  16. Treatment for HIV/HCV coinfection in Taiwan • Standard of care in coinfected patients is pegylated interferon plus ribavirin • Optimal dosing of pegylated interferon and ribavirin • HCV genotype 1, ribavirin (1000 mg/day if < 75 kg and 1200 mg/day if > 75 kg) • HCV genotype 2 & 3, ribavirin (800 mg/day) • F/U HCV RNA at 12, 24, 48 wks, and 6 months • F/U HIV RNA every 3-4 months (NHRI National Hepatitis BC Forum, 2008)

  17. Topics • Molecular epidemiology of HIV/HCV coinfection in Taiwan • Treatment and care for patient with HIV/HCV coinfection in Taiwan • Challenges of management of HIV/HCV coinfection in Taiwan

  18. Needle-Syringe Programming • Pilot stage (Nov. 2005 ) (76 NSP stations) • Expanding stage (Jul. 2006 ) (427 NSP stations) • Present stage (Jan. 2008) (1103 NSP stations)

  19. 基隆長庚醫院/署立基隆醫院 台北市立聯合醫院松德院區*/疾管院區*/三軍總醫院 桃園療養院*/國軍桃園總醫院*/桃園榮院* 八里療養院*/耕莘醫院*/亞東醫院*/署立台北醫院* 新竹馬偕醫院* 羅東博愛*/署立宜蘭醫院 署立新竹醫院/署立竹東醫院 為恭醫院* 中國附設醫院* 署立草屯療養院* 童綜合醫院* 國軍花蓮總醫院*/署立花蓮醫院 彰化基督教醫院*/署立彰化醫院 嘉義榮民醫院*/署立嘉義醫院 台大雲林分院*/中國北港/若瑟醫院* 署立朴子醫院*/大林慈濟醫院 署立台東醫院* 署立嘉南療養院*/永康榮院*/署立新營醫院* 署立台南醫院*/成大醫院*/奇美醫院 高雄長庚* /慈惠醫院* 市立凱旋醫院*/國軍高雄醫院 安泰醫院* Drug Substitution Treatment Pilot stage (Feb. 2006 ) (6 hospitals) Expanding stage (Aug. 2006 ) (33 hospitals & clinics) Present stage(Jan. 2008 ) (68 hospitals & clinics)

  20. Health seeking behaviors among patients with HIV categorized by route of transmission CH Yang (2006) HIV-related Medical Expenditure Analysis in Taiwan

  21. Challenges of management of HIV/HCV coinfection in Taiwan • Harm reduction policy was implemented since 2006 • HCV treatments founded by NHI were performed by hepatologists, oncologists, and hematologists • Current standards include presence of progression based on liver biopsy • Some hepatologists still withhold treatment from patietns with HIV or IDUs • Cost of test for HCV RNA and genotype

  22. Conclusions • HCV infection is highly prevalent in HIV-infected IDUs and exhibit great genetic diversity. • HIV-1 CRF07_BC, HCV genotype-1a, 3 and 6 have been transmitted from China into Taiwan through drug trafficking route. • Pegylated interferon plus ribavirin is available. • Some hepatologists still withhold treatment from patients with HIV or IDUs. • Poor access to care and fewer clinical visits among HIV infected IDUs.

  23. Acknowledgements • Taiwan CDC: Dr. CH Yang • EDH: Dr. HH Lin • NTUH: Dr. CC Hung, Dr. WH Sheng • KMUH: Dr. ML Yu • NHRI: Dr. IJ Su,Dr. FC Tseng

  24. Thanks your attention

More Related